BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 36038092)

  • 21. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
    Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
    BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aqueous extract of Paeoniae Radix Alba (Paeonia lactiflora Pall.) ameliorates DSS-induced colitis in mice by tunning the intestinal physical barrier, immune responses, and microbiota.
    Yan BF; Chen X; Chen YF; Liu SJ; Xu CX; Chen L; Wang WB; Wen TT; Zheng X; Liu J
    J Ethnopharmacol; 2022 Aug; 294():115365. PubMed ID: 35597411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An inulin-type fructan CP-A from Codonopsis pilosula attenuates experimental colitis in mice by promoting autophagy-mediated inactivation of NLRP3 inflammasome.
    Zhou J; Wang J; Wang J; Li D; Hou J; Li J; Bai Y; Gao J
    Chin J Nat Med; 2024 Mar; 22(3):249-264. PubMed ID: 38553192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Main active components of Ilex rotunda Thunb. protect against ulcerative colitis by restoring the intestinal mucosal barrier and modulating the cytokine-cytokine interaction pathways.
    Li Y; Tian YY; Wang J; Lin R; Zhang Y; Zhang MM; Dong TW; Li M; Xie YH; Zheng XH; Yang Q; Yuan JN; Si-Wang W
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116961. PubMed ID: 37541404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcandra glabra (Thunb.) Nakai alleviates DSS-induced ulcerative colitis by promoting restitution, restoring barrier function, and modulating IL-17/Notch1/FoxP3 pathway in intestinal cells.
    Zhang S; Li Y; Chen G; Wang X; Wu B
    J Ethnopharmacol; 2024 Jun; 328():118131. PubMed ID: 38565408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
    Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
    J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-κB pathway.
    Xiong T; Zheng X; Zhang K; Wu H; Dong Y; Zhou F; Cheng B; Li L; Xu W; Su J; Huang J; Jiang Z; Li B; Zhang B; Lv G; Chen S
    J Ethnopharmacol; 2022 May; 289():115001. PubMed ID: 35085745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of Lizhong decoction on ulcerative colitis in mice by suppressing inflammation and ameliorating gut barrier.
    Shen Y; Zou J; Chen M; Zhang Z; Liu C; Jiang S; Qian D; Duan JA
    J Ethnopharmacol; 2020 Sep; 259():112919. PubMed ID: 32360800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canna x generalis L.H. Bailey rhizome extract ameliorates dextran sulfate sodium-induced colitis via modulating intestinal mucosal dysfunction, oxidative stress, inflammation, and TLR4/ NF-ҡB and NLRP3 inflammasome pathways.
    Mahmoud TN; El-Maadawy WH; Kandil ZA; Khalil H; El-Fiky NM; El Alfy TSMA
    J Ethnopharmacol; 2021 Apr; 269():113670. PubMed ID: 33301917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Syringaresinol attenuates ulcerative colitis by improving intestinal epithelial barrier function and inhibiting inflammatory responses.
    Liu Y; Wu J; Tan L; Li Z; Gao P; He S; Wang Q; Tang D; Wang C; Wang F; Li P; Liu J
    Phytomedicine; 2024 Feb; 124():155292. PubMed ID: 38190784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Network pharmacology mechanisms and experimental verification of licorice in the treatment of ulcerative colitis.
    Kong J; Xiang Q; Ge W; Wang Y; Xu F; Shi G
    J Ethnopharmacol; 2024 Apr; 324():117691. PubMed ID: 38176667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mo
    Guo H; Guo H; Xie Y; Chen Y; Lu C; Yang Z; Zhu Y; Ouyang Y; Zhang Y; Wang X
    Redox Biol; 2022 Oct; 56():102441. PubMed ID: 35985164
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Li ZY; Lin LH; Liang HJ; Li YQ; Zhao FQ; Sun TY; Liu ZY; Zhu JY; Gu F; Xu JN; Hao QY; Zhou DS; Zhai HH
    Ann Med; 2023; 55(2):2290213. PubMed ID: 38061697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nitazoxanide protects against experimental ulcerative colitis through improving intestinal barrier and inhibiting inflammation.
    Zhu HT; Luo J; Peng Y; Cheng XF; Wu SZ; Zhao YD; Chang L; Sun ZJ; Dong DL
    Chem Biol Interact; 2024 May; 395():111013. PubMed ID: 38663798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberrubine attenuates mucosal lesions and inflammation in dextran sodium sulfate-induced colitis in mice.
    Yu XT; Xu YF; Huang YF; Qu C; Xu LQ; Su ZR; Zeng HF; Zheng L; Yi TG; Li HL; Chen JP; Zhang XJ
    PLoS One; 2018; 13(3):e0194069. PubMed ID: 29538417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation.
    Hu ML; Liao QZ; Liu BT; Sun K; Pan CS; Wang XY; Yan L; Huo XM; Zheng XQ; Wang Y; Zhong LJ; Liu J; He L; Han JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117098. PubMed ID: 37640256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sanhuang Xiexin decoction ameliorates DSS-induced colitis in mice by regulating intestinal inflammation, intestinal barrier, and intestinal flora.
    Wu X; Fu S; Jiang M; Wang J; Tang H; Fang C; Li W; Fu C
    J Ethnopharmacol; 2022 Oct; 297():115537. PubMed ID: 35843414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cis-Nerolidol Inhibits MAP Kinase and NF-κB Signaling Pathways and Prevents Epithelial Tight Junction Dysfunction in Colon Inflammation: In Vivo and In Vitro Studies.
    Raj V; Venkataraman B; Ojha SK; Almarzooqi S; Subramanian VS; Al-Ramadi BK; Adrian TE; Subramanya SB
    Molecules; 2023 Mar; 28(7):. PubMed ID: 37049744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.